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Abstract
Background: Diabetes is a chronic illness, which requires the individual to assume responsibility
for their own care with the aim of maintaining glucose and blood pressure levels as close to normal
as possible. Traditionally self-management training for diabetes has been delivered in a didactic
manner. In recent times alternatives to the traditional delivery of diabetes care have been
investigated, for example, the concept of peer support which emphasises patient rather than
professional domination. This paper describes the pilot study and protocol for a study that aims to
evaluate the effectiveness of a peer support intervention for people with type 2 diabetes in a
primary care setting.
Methods/Design: A pilot study was conducted to access the feasibility of a randomized controlled
trial of a peer support intervention. We used the MRC Framework for the evaluation of complex
interventions. Elements of the intervention were defined and the study protocol was finalized. In
this cluster randomised controlled trial twenty general practices are assigned to control and
intervention groups. Each practice compiles a diabetes register and randomly selects 21 patients.
All practices implement a standardised diabetes care system. In the intervention group all practices
recruit three peer supporters. The peer supporters are trained to conduct nine group meetings in
their general practice over a period of two years. Each meeting has a structured component. The
primary outcomes are blood pressure, total cholesterol, HBA1c and the Diabetes Well-being
score. In addition to biophysical, psychosocial, economic and health service utilization data peer
supporter activity and qualitative data are collected.
Discussion: Peer support is a complex intervention and evaluating such an intervention presents
challenges to researchers. This study will evaluate whether a peer support programme for patients
with type 2 diabetes improves biophysical and psychosocial outcomes and whether it is an
acceptable, cost effective intervention in the primary care setting.
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Background
Improving outcomes in type 2 diabetes
The management of type 2 diabetes has traditionally
focused on the lifestyle changes and medication that can
improve blood sugar or glycaemic control. However, the
United Kingdom Prospective Diabetes Study (UKPDS)
and the Steno-2 study highlighted the importance of com-
bining tight glycaemic control and cardiovascular risk
reduction such as blood pressure control if long term
complications are to be prevented or reduced [1,2]. Two
Cochrane reviews of diabetes care concluded that care
should be structured with regular prompting for patients
and their family doctors; that multifaceted interventions
can enhance professional performance and that the addi-
tion of patient-oriented interventions can improve out-
comes [3,4]. Other research has focused on interventions
to change diabetes-related behaviours or interventions
that can enhance patient self-management [5,6].
However, more recent international studies failed to make
significant impact on biophysical risk factors such as
blood pressure, cholesterol and glycosylated haemo-
globin (HBA1c) [7-10]. There is evidence that standards of
diabetes care are suboptimal in many countries [11,12].
Questions remain as to the type or types of interventions
that can significantly improve outcomes in individuals
with type 2 diabetes.
Peer support
Peer support has been formally defined as the "the provi-
sion of emotional, appraisal, and informational assist-
ance by a created social network member who possesses
experiential knowledge of a specific behaviour or stressor
and similar characteristics as the target population, to
address a health-related issue of a potentially or actually
stressed focal person" [13]. This definition of peer support
falls within the social support model, which is defined as
the process through which social relationships might pro-
mote health and well-being [14]. A peer may have a
greater understanding of an individuals situation than a
member of their own family or social network who may
feel uncomfortable about an issue or may be too upset to
provide support [15]. Within the social support model,
the direct effect model would postulate that peer support
could reduce feelings of isolation and loneliness, provide
information about access to health services or the benefits
of behaviours that positively improve health and well-
being and encourage more positive health practices [13].
Qualitative studies with people with type 2 diabetes have
highlighted the value they place in learning from the expe-
rience of others [16] and the potential gap between
knowledge and understanding, with a need for more
"understandable information" in "layman's language"
[17]. This could be addressed through a peer support
intervention. A peer supporter is a type of lay health
worker, who are defined in a Cochrane review as individ-
uals who carry out functions related to health care deliv-
ery; are trained in some way in the context of an
intervention and have no formal related professional or
paraprofessional qualification [18]. The use of non-pro-
fessional volunteers has improved outcomes in other
diverse health settings such as maternal child health
development [19] and cardiac surgery [20]. A participa-
tory intervention using lay facilitators with womens'
groups led to a significant reduction in neonatal mortality
[21]. The dramatic success of this intervention has been
attributed in part to the 'remarkable capacity and altruism'
of the lay women facilitators but also to the fact that it was
a well-targeted demand-side intervention [22].
Unlike the peer led educational interventions such as the
Chronic Disease Self-Management Programme (CDSMP)
[23] devised by Kate Lorig the intervention in this study
focuses more on social support than education.
Evaluation of peer support
Peer support is a complex intervention and ideally should
be evaluated using a framework such as the Medical
Research Council Framework for Development and Eval-
uation of Randomised Controlled Trials for Complex
Interventions to Improve Health [24]. This framework
highlights the importance of adequate modelling and
exploration or piloting of the intervention prior to com-
mencement of the full randomised controlled trial. It
stresses the importance of comparing a fully defined inter-
vention with an appropriate alternative and ensuring that
the intervention can be replicated to facilitate long-term
implementation. The importance of a process evaluation
of a randomised controlled trial, which incorporates a
qualitative component and includes a consideration of
treatment fidelity, has also been emphasized [25-28]. We
have used the MRC framework to develop the peer sup-
port intervention for this study and this process is
described in detail elsewhere (submitted to BMC Health
Services Research, in press). There is also increasing recog-
nition of the importance of a parallel health economic
analysis when carrying out a randomised controlled trial
of an intervention with potential to improve health out-
comes [29]. Costs must be considered when evaluating
new treatments and this is particularly the case for a con-
dition such as type 2 diabetes, which has enormous costs
for individuals and healthcare systems [30].
Methods/Design
Pilot study
The pilot study was carried out in two general practices,
one a small single-handed practice and the other a large
group practice. Both practices have a practice nurse and
computerized record systems. Twenty four patients andBMC Family Practice 2007, 8:45 http://www.biomedcentral.com/1471-2296/8/45
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four peer supporters from the practices participated. Some
characteristics of the participants are presented in Table 1.
The peer supporters, who were selected by the GPs,
attended two evening training sessions conducted by the
research team. Each peer supporter facilitated three ses-
sions with participating patients. These sessions were held
in the general practices for approximately an hour and a
half.
The qualitative evaluation of the pilot study indicated that
patients were positive about their experience of peer sup-
port-"very helpful because you are going into a hospital,
seeing a doctor, but you are not seeing other people who
have it like ourselves" (FG1, Participant 3). The patients
were also positive regarding the professional diabetes edu-
cation services but many felt that healthcare professionals
may not be familiar with the day to day issues which arise
when living with diabetes. Patients felt that a peer would
serve as a motivating factor in both encouraging diabetes
behaviours and in lifestyle modification. Peer supporters
described the experience as "very positive" (FG7 Partici-
pants 4,5). They reported that the patients in their groups
were interested in simple practical information- "the peo-
ple are not looking for a theoretical understanding of it,
you know they don't want to know the latin" (FG7, Partic-
ipant 6). Potential barriers, such as confidentiality and
intrusiveness were dismissed by patients and peer sup-
porters. Payment was largely viewed as against the spirit of
peer support though participants felt expenses should be
covered. Practice staff reported that the patients appeared
to enjoy the contact with each other and the study had lit-
tle negative impact on their work or the day to day run-
ning of the practice.
These pilot results are in keeping with a recent UK study
looking at the role of lay health advisers in diabetes [31].
Health professionals and patients were interviewed and
both were broadly supportive of the concept of lay advi-
sors following the development of lay criteria, structured
training and guidelines. Patients indicated a preference for
a lay advisor over an unknown health professional and
they identified the ability of lay advisors to enhance and
support diabetes patient self-management. Several peer
support or 'buddy' projects are being piloted in the UK
though none are currently being evaluated using a rigor-
ous methodology such as a randomised controlled trial
[32].
Randomised controlled trial
Objective
To determine whether a peer support programme for
patients with type 2 diabetes improves biophysical and
psychosocial outcomes and whether it is an acceptable,
cost effective intervention in the primary care setting
The study is a cluster randomised controlled trial where
general practices are allocated into one of two groups:
1. Control practices: implement a standardised diabetes
care system for the 21 study patients (see below).
2. Intervention practices: implement the standardised dia-
betes care system and the peer support intervention (see
below)
Identification and recruitment of practices and patients
Practice identification
Twenty practices will be identified from the Trinity Col-
lege/Health Service Executive General Practice Training
Programme and the Trinity College network of under-
graduate teaching practices. They all have a practice nurse
and vary from single-handed practices to multi-partner
practices with the largest practice having five full time
equivalent partners. They include a mixture of urban, sub-
urban and rural practices.
The GP's are provided with information about the study.
They are then contacted by the research team and asked if
they are interested in participating in the study. If they
agree to participate the project manager visits the practice
and discusses the study in more detail. During this meet-
ing the project manager gets commitment to the study and
one GP and practice nurse are identified as managing the
programme at practice level. Participating practices are
given a grant of €5000 per annum for three years (€1000
of which is allocated to the practice nurse). Practices are
eligible to participate if they have a practice nurse; have
computerized records; did not participate in the pilot
study; have a minimum GMS (General Medical Services
scheme, see Table 2) list of approx 1000 patients and/or
have > 50 patients on their register of patients with type 2
diabetes; and are not participating in an existing shared
care diabetes programme involving structured care
between the general practices and hospital diabetes serv-
ice.
Table 1: Personal characteristic of the patients and peer 
supporters that participated in the pilot study
Patient 
participants
Peer 
supporters
Male 13 (59%) 4 (100%)
Mean age (yrs) 66 65
Mean (yrs) since diagnosis of type 2 
diabetes
47
Entitled to medical card 14 (64%) 2 (50%)
Smoker 3 (14%) 0 (0%)BMC Family Practice 2007, 8:45 http://www.biomedcentral.com/1471-2296/8/45
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Patient identification (21 patients per practice)
Participating practices compile a list of eligible patients
from their practice to create or update their diabetes regis-
ter. A combination of approaches to compile the register
are used including personal recollection of practitioners,
identification of patients through computerized prescrib-
ing of diabetes related medications and if necessary using
computerized records of local pharmacies. Diagnosis of
type 2 diabetes is confirmed by double-checking patient
records. Only patients agreeing to participate in the inter-
vention and who provide baseline data collection will be
recruited into the trial. Details of those declining to partic-
ipate will be recorded including age, gender, GMS status,
duration of diabetes and diabetes treatment. A patient is
eligible to participate if they are over 18 years of age; have
type 2 diabetes and attend participating practices. A
patient will be excluded if they have significant mental or
physical illness which is likely to impair their capacity to
participate in the programme
Randomisation
Practice allocation
Practices will be stratified by practice size (less than two or
two or more whole-time-equivalent GPs) and presence of
existing structure primary diabetes care service. They will
then be allocated to intervention or control groups using
minimization [34]. Allocation will be carried out inde-
pendently of the research team. It will occur prior to
patient identification and baseline data collection. While
it is regarded as best practice to randomize after baseline
data collection, in this study allocation must take place in
this sequence to facilitate the recruitment of peer support-
ers from the patient register in intervention general prac-
tices before the randomisation of patients and the
beginning of the intervention.
Patients: random selection
Once a complete diabetes register is established, the
project manager assists the practices in using a list of ran-
dom numbers to select patients for participation. All
patients on the register are allocated a number 1 to Y
(where Y is the total number of patients on the list). Ran-
domly selected patients are sent an invitation letter, infor-
mation sheet and reply slip. Patients who do not respond
in two weeks are contacted by telephone by the practice
nurse to ascertain interest in participation. If a patient
does not meet the eligibility criteria or declines to partici-
pate the next patient is selected from the list until the
quota of 21 is reached. (Figure 1)
Basic characteristics of patients who decline to participate
will be collected including date of birth, sex, GMS status,
duration of diabetes and reason for not participating.
Sample size calculation
The study aims to achieve a sample of 410 patients from
20 practices. This takes into account the effect of cluster
randomisation and allows for 80–85% patient follow up
and a 15% practice attrition rate (though the authors pre-
vious experience of cluster randomized trials in this set-
ting indicate much lower patient and practice attrition
rates [10]). Sample size calculations are based on a 20%
improvement from baseline in the control group and 50%
Flow of practices and patients throughout the trial Figure 1
Flow of practices and patients throughout the trial.
Recruit 20 practices and establish practice profile
Create practice register
Practice randomisation
Intervention Group Control Group
Random selection of 21 patients    Random selection of 21 patients
   Consent and   Consent and 
baseline data collection baseline data collection 
   (including focus groups)    (including focus groups)
Standardised diabetes care   Standardised diabetes care
Peer support intervention
Follow up data collection
(including focus group)
Table 2: The General Medical Services scheme
THE GENERAL MEDICAL SERVICES SCHEME [33]
-Free medical and surgical health services for those on low income and for everyone over 70 yrs of age
-An eligible person is entitled to select a General Practitioner of their choice, from those doctors who have entered into agreements with the 
Health Service Executive
-29.5% of the population are entitled to a medical cardBMC Family Practice 2007, 8:45 http://www.biomedcentral.com/1471-2296/8/45
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improvement in the intervention group [35]. All calcula-
tions are two-sided and based on an alpha of 5% and a
power of 80%.
Systolic Blood pressure (SBP)
46% of patients, in a previous study in Dublin, have a SBP
>160 mmHg [10]. This level of SBP represents very poorly
controlled blood pressure as the current upper recom-
mended limit for an individual with type 2 diabetes is 130
mmHg [36]. The intracluster coefficient (ICC) for SBP is
0.001 [10]. A sample size of 400 patients from 20 prac-
tices is needed to show a significant improvement in the
proportion of patients with a SBP below 160 mmHg (i.e.
50% improvement in intervention group and 20%
improvement in control group as above).
HBA1c
A sample size of 130 patients from 8 practices is needed to
demonstrates a clinically significant difference in mean
HBA1c between intervention and control groups (i.e a dif-
ference of 0.9% [37], standard deviation 1.6; ICC 0.001
[10])
Cholesterol
57% of patients have a total cholesterol >5 mmol [10],
which is the upper recommended limit for patients with
type 2 diabetes [38] (ICC = 0.06) [10]. A sample size of
410 patients from 20 practices is needed to show a signif-
icant improvement in the proportion of patients with a
cholesterol <5 mol/l.
Well-being scores (WBS)
A sample size of 221 patients from 12 practices is needed
to show a clinically significant difference in WBS between
intervention and control groups (i.e. a mean difference of
5 points, standard deviation, 10.3; ICC of 0.07) [10].
GP and Practice nurse training
The GP's and practice nurses receive a practice based train-
ing session. This 1.5 hour session is conducted by a GP on
the research team. The content focuses on the treatment of
type 2 diabetes in primary care.
Practice nurses attend three training sessions conducted
by the research team. The sessions are outlined below:
Session 1 (Prior to baseline data collection)
Introduction to project
Random selection of patients from register
Recruitment of participants: letter, phonecall, details of
non-responders
Data collection: Information to give to potential partici-
pants
Informed consent
Questionnaire completion
Performing biophysical measurements
Confidentiality
Computer skills/imputing data
Session 2 (Prior to the commencement of the intervention)
Diabetes care in primary care (including annual audit)
Setting up a recall system
Session 3 (Prior to follow up data collection)
Refresher of data collection procedures
Standardised diabetes care
All participating practices are trained and supported to
introduce a standardised primary diabetes care system.
This is to avoid the lack of clarity that can result if 'usual
care' is used for the control arm of a randomised control-
led trial. This diabetes care system includes:
• Practice based training for GPs and practice nurses (as
above)
• Agreement and implementation of evidence based clin-
ical guidelines
• Structured registration and recall every four months of
patients with type 2 diabetes to specific diabetes appoint-
ments or mini-clinics with practice nurses supported by
GPs
• Provision of treatment algorithms designed to optimise
glycaemic control and reduce cardiovascular risk
• Use of a 'target card', a patient held record of results
relating to their diabetes
• Educational resources
• Annual practice audit
Practices with existing structured care (three of the
twenty), have agreed to incorporate these components
into their current systemBMC Family Practice 2007, 8:45 http://www.biomedcentral.com/1471-2296/8/45
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Intervention
Intervention practices, deliver a peer support intervention
which has the following components:
1. Peer supporters
Potential peer supporters are identified by GPs and prac-
tice nurses in the intervention practices. Peer supporters
are recruited and trained at a ratio of approximately one
peer supporter to seven/eight patients with type 2 diabe-
tes. They are eligible to be trained if they meet the follow-
ing inclusion criteria:
• They have had type 2 diabetes for at least one years dura-
tion
• They participate in preventive treatments and are gener-
ally adherent to treatment and behaviour change regi-
mens, as judged by the practice team
• They have a capacity and commitment to undergo the
training required (outlined below)
• They have a full understanding of the importance of
patient confidentiality
• They undertake to liaise with the practice nurse and/or
GP if unanticipated problems arise during the course of
their peer support activity
2. Peer supporter training
The peer supporters attend two evening training sessions,
which are conducted by the research team. The content of
these sessions is outlined below:
Session 1
Introduction to the project
Role of the peer supporter
Basics of type 2 diabetes
Complications of type 2 diabetes
Session 2
Lifestyle and medication issues
Communication skills and working with groups
Role play
Confidentiality
Support for the peer supporters
The two sessions will focus on the materials to be used
during the group meetings (described below) and peer
supporters will each receive a pack with resource material
to support these training sessions.
3. Retention and support of peer supporters
Retention of peer supporters is crucial to the study. Struc-
tures are in place to ensure peer support workers are sup-
ported in the role. They include:
• Feasible time commitment to the project
• Outline of responsibilities/peer support policy
• Adequate training (outlined above)
• Course handbook and resource pack
• Contact details and explicit support from the project
team and GP/practice nurse
• Telephone call from project manager following each ses-
sion
• Annual social event
• Protocol to follow if a peer supporter resigns (see below)
• Travel and related expenses
If a peer supporter resigns from their position a substitute
will be nominated from their group. At the beginning of
the intervention the peer supporters and their groups will
be asked to nominate one group member who would be
a suitable replacement for him/herself if the need were to
arise. An individual will receive the same training as the
original peer supporters if they need to take on the full
role of peer supporter. The peer support intervention
operates within a volunteer framework, which involves
reimbursement for travel and communication expenses
rather than actual payment for work involved.
4. Peer support meetings
Peer support meetings are held in the general practice
premises at a convenient time for practice staff, peer sup-
porters and participants. The intervention consists of nine
peer support sessions held over two years; at month 1,
month 2 and every 3 months thereafter. The exploratory
phase revealed that both peer supporters and patients
agree that each meeting should have a focus and a small
structured component, for example, a ten to fifteen
minute discussion on a particular aspect of diabetes man-
agement (see Table 3 for a summary of the meeting con-
tent. Peer supporters receive more information including
a list of potential questions to put to the group on eachBMC Family Practice 2007, 8:45 http://www.biomedcentral.com/1471-2296/8/45
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topic). A need was also identified for a "frequently asked
questions" system. That is, at the end of each session there
is general discussion and the group identifies and records
any questions regarding the session topic. These are fed
back to the research team who compile written answers
based on the feedback from all groups, which are pre-
sented and discussed at the start of the next session.
Informed consent and ethical approval
An invitation and information sheet is sent to the ran-
domly selected eligible patients. Patients are asked to sign
and return a reply slip if they are interested in participat-
ing. They are contacted by the practice nurse and an
appointment is made for them to visit the practice for
baseline data collection. Prior to baseline data collection
the practice nurse reads the information sheet to the
patient, allowing them to ask any questions and confirm-
ing their willingness to participate in the study. The prac-
tice nurse then asks the patient to sign the consent form.
Ethical approval has been obtained from the Ethics Com-
mittee of the Irish College of General Practitioners (Proto-
col No.: REC0904-11; 01/12/04)
Data collection
Data collection is carried out in the practices by practice
nurses, following training by the project manager. Data
are collected at baseline and on study completion at two
years. The following forms of data are collected:
1. Questionnaire: given to patients as they wait to see the
practice nurse. It is then checked for completeness of data
entry and the nurse assists any patient who requires help
in completing the questionnaire measures
Table 3: Content of peer support meetings
MEETING 1 MEETING 2
INTRODUCTION HEART AND VASCULAR DISEASE
• Introduction to each other
• What is peer support?
• Ground rules
• Discussion on course content (9 sessions)
• Video/DVD 15 mins
• Entitlements in diabetes
• Identifying a substitute peer supporter
• Contact details for the group
• Why is it so important?
• How you can reduce your risk of heart disease and other vascular 
complication
❍  Hypothetical individual and what they would advise them to do
Questions relating to heart disease including blood pressure and 
cholesterol medication and taking tablets
MEETING 3 MEETING 4
BLOOD SUGAR LEVELS HEALTHY EATING
• Information on hypo/hyperglycaemia
• Blood sugar testing
Questions on blood sugar levels
What to do when you are sick
Discussion of healthy 'eating plate'
• Laminated picture of the 'healthy plate'
Healthy eating quiz and discussion of answers
Questions on healthy eating in diabetes
MEETING 5 MEETING 6
MEDICATION EXERCISE
• Control of type 2 diabetes
❍  Diet
❍  Tablets
❍  Insulin
Questions regarding medication including side effects
• Importance of exercise
• Use of a pedometer
❍  each person will be given a pedometer
Questions about exercise
Maybe arrange a walk in locality
MEETING 7 MEETING 8
FOOT CARE EYE AND KIDNEY COMPLICATIONS
• Why foot care matters in diabetes
• Discussion on how to check feet
❍  Laminated sheet to cover all aspects of foot care
Questions relating to the feet
Information on local chiropody services
• What happens to the eyes and kidneys in diabetes
• Importance of good blood pressure and blood sugar control in order 
to prevent complications
Questions relating to eye and kidney disease
MEETING 9
LIVING WITH DIABETES
This is intended to be a relatively open session in which the group can 
discuss any remaining concerns and consider whether they would like to 
continue to meet
Importance of follow up data collection!BMC Family Practice 2007, 8:45 http://www.biomedcentral.com/1471-2296/8/45
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2. Consultation and biophysical data: gathered by practice
nurse
3. GP record search: to establish process of care and collect
patient outcomes recorded in GP records, carried out by
practice nurse.
4. Peer support activity: Peer supporters will keep a diary
of their activity (outlined below)
Questionnaire
The questionnaire includes:
• Personal and demographic variables
❍  Name, date of birth, marital status,
❍  Educational level
• Economic variables
❍  Occupation
❍  General Medical Services eligibility
❍  Journey times to GP practice and hospital
• Health service utilization
❍  Number of visits to GP practice (recorded by practice
nurse)
❍  Number of visits to diabetes day centre (recorded by
patient)
❍  Number of visits to OPD to see a specialist (recorded by
patient)
• Peer support utilisation
❍  Peer support contacts: number, nature, duration
(recorded by peer supporter)
• Psychosocial
❍  Well-being score [39]
❍  Diabetes self-care activities [40]
❍  Self-efficacy [41]
❍  Measure of medication adherence [42]
❍  Family and friends subscale of the Chronic Illness
Resources Survey [43]
Consultation and biophysical data
The following biophysical measurements are collected:
• Blood Pressure
• HBA1c
• Cholesterol: Total random cholesterol
• Body mass index
GP record search
Patient charts are searched by the practice nurse and proc-
ess of care information recorded:
• Number of GP visits
• Number of practice nurse visits
• Patients medical history: disease counts to establish
multimorbidity
• Patients medication
Peer support activity
Peer supporters fill out a diary of their peer support activ-
ity after each peer support meeting. They document the
following information:
• Number of peer support meetings
• Nature of meeting
❍  Number and names of people attending
❍  Topics discussed
❍  Problems arising
• Time commitment to study
Data analysis
All results will be analysed using STATA statistical soft-
ware [44] which has a facility for complex survey sample
analysis that allows for adjustments in data analysis based
on design effects, planned or unplanned. Analyses will be
carried out using two approaches:
• by intention to treat i.e. including all randomized
patients, regardless of their participation in the interven-
tion.
• Sensitivity analyses will explore whether adherence to
the intervention influences the effect of the intervention
on primary outcomesBMC Family Practice 2007, 8:45 http://www.biomedcentral.com/1471-2296/8/45
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Participating patients will be described in terms of:
• Age
• Gender
• Date of diabetes diagnosis
• Single/Multimorbidity
• Socioeconomic status
Practices will be described as follows:
• Number of GPs (WTE)
• Number of practice nurses (WTE)
• Number of administrative staff (WTE)
• Practice size (No of GMS patients and total number of
patients)
• Practice geographical location
Randomised control trial analysis
Primary outcomes
• Blood pressure
• Total cholesterol
• HBA1c
• Well being score
Secondary outcomes
• Biophysical
❍  BMI
• Measure of processes of care
❍  GP visits
❍  Practice nurse visits
❍  Hospital OPD visits
❍  Hospital diabetes centre visits
❍  Hospital admissions
• Psychosocial measures and medication adherence
❍  Diabetes self-care activities
❍  Self-efficacy
❍  Measure of medication adherence
❍  Smoking
• Medication
❍  Aspirin
Data management
The project manager has the overall responsibility for
compilation, maintenance and management of the study
database. The database is stored on a password-protected
computer in a locked office.
Practice nurses receive training in data collection and have
responsibility for completeness, accuracy and confidenti-
ality of the data within participating practices. Data are
entered onto a study laptop, onto a File Maker Pro [45]
file by the practice nurse in participating practices. Study
files are password protected. Each patient has a unique
study number. The data are collected by the project man-
ager and merged with the main study database. The data
from each practice are merged, checked, cleaned and
transferred into STATA.
The project manager double checks the questionnaires
and patient records in each practice to ensure data collec-
tion and entry is accurate and complete.
Treatment fidelity
Treatment fidelity is the strategy used to monitor and
enhance the reliability and validity of behavioural inter-
ventions [46]. This study uses elements of a framework
developed by Bellg et al to make treatment fidelity explicit
[27]. The framework consists of five treatment fidelity
strategies: Treatment design, Training procedures, Deliv-
ery of treatment, Receipt of treatment and Enactment of
treatment skills. Details of how the strategy is imple-
mented in this study are presented in the Table 4.
Qualitative evaluation
A descriptive parallel qualitative analysis is being carried
out to record patients, professionals and peer supporters
attitudes to peer support and their experience of its deliv-
ery in intervention practices. It will be based on descrip-
tive phenomenology. Descriptive phenomenology is one
of several qualitative research traditions. It seeks to under-
stand the lived experience of individuals. It answers ques-
tions such as "What is it like to have a certain
experience?"[47]. It is becoming increasingly relevant to
health service research as it provides insight into service
users and providers' experiences and stories [48].BMC Family Practice 2007, 8:45 http://www.biomedcentral.com/1471-2296/8/45
Page 10 of 13
(page number not for citation purposes)
In the intervention group the qualitative evaluation will
explore questions such as
1. What are the current support and resources for people
with type 2 diabetes?
2. Peer support
• What is the participants' understanding of peer support?
• Is peer support an acceptable intervention?
• How does peer support work?
• Was the intervention successfully implemented?
• Did the programme benefit the peer supporters?
• Will people take up this service in the future if it was
offered?
3. Standardised diabetes care programme
• Was the standardised diabetes care programme success-
ful?
• Were patients satisfied with the programme?
4. Did the intervention and standardised diabetes care
programme significantly increase the practice staff's work-
load?
In the control group the qualitative evaluation will
explore questions such as:
1. What are the current support and resources for people
with type 2 diabetes?
2. Standardised diabetes care programme
• Was the standardised diabetes care programme success-
ful?
• Were patients satisfied with the programme?
3. Did the standardised diabetes care programme signifi-
cantly increase the practice staff's workload?
Qualitative data collection and analysis
Data will be collected at baseline and follow up. Both
focus groups and semi-structured interviews will be con-
ducted among patients, peer supporters and practice staff:
• Patients (4 focus groups)
• Peer supporters (2 focus groups)
• GPs (4 semi structured interviews)
• Practice nurses (4 semi structured interviews)
Stratified purposeful sampling will be used in order to
include patients, peer supporters and staff from both
urban/rural practices, small/large practices and from
deprived and affluent areas. Patients and peer supporters
will be invited to participate in the focus groups by letter,
which will be followed up by a telephone call from the
practice nurse. Staff will be invited to participate by the
project manager.
Table 4: Framework of treatment fidelity strategies
Treatment design Information provided about intervention
Length of peer support meetings (1 to 1.5 hrs)
Number of peer support meetings (9)
Duration of intervention (2 yrs)
Information provided on standardized care
Number of routine visits to GP/practice nurse (every 4 months)
Training procedures Training of GP and practice nurse outlined
Practice based session for GPs and practice nurses
Three training sessions for practice nurses
Training of peer supporters outlined
Two evening sessions
Delivery of treatment Assurance that intervention has been delivered as per protocol
Peer supporter manual
Project manager contacts every peer supporter after each of their group meetings
Peer supporters fill in log diaries
Focus groups with participants, peer supporters and professionals
Receipt of treatment Record of each participant's attendance at meetings
Peer supporter takes a record at each meetingBMC Family Practice 2007, 8:45 http://www.biomedcentral.com/1471-2296/8/45
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Interview schedule
The interviews and focus groups will be audio-taped and
transcribed verbatim.
The analysis will involve reading the transcripts, identifi-
cation and transforming meaning units, formulation of
essential general structure or structures and finally formu-
lating the exhaustive description of the phenomenon. Sev-
eral methods of improving validity of qualitative research
will be conducted including respondent validation, clear
explanation of methods of data collection and analysis,
reflexivity and audit trails. The software package, Atlas,
will be used to assist with organization and analysis of the
data.
Process evaluation
Data from the peer supporter log diaries and the project
manager's record of contact with the peer supporters is
analysed, in addition to the above qualitative data, to
evaluate the process of the implementation of the inter-
vention.
Economic evaluation
The economic evaluation will examine whether the inter-
vention is associated with overall cost increases or cost
decreases and will link the cost changes to incremental
gains in effectiveness and primary outcomes. The basic
tasks of the economic evaluation are to identify, measure,
value and compare the costs and outcomes of the addition
of peer support to a standardised primary diabetes care
system. Unit costs will be applied to the resource use data
to calculate the various costs of care. The primary focus
will be on cost effectiveness analysis [49]. Presenting the
results of cost effectiveness studies requires reporting the
incremental costs and effects of a new intervention rela-
tive to an alternative and then reporting an incremental
cost effectiveness ratio (incremental costs divided by
incremental effects). In this study the cost effectiveness
analysis will provide information on the marginal costs
and effects of the intervention relative to the alternative
through the calculation of incremental cost-effectiveness
ratios using the primary outcomes: blood pressure, total
cholesterol, HBA1c and diabetes well-being. Incremental
cost-effectiveness ratios will be calculated in all circum-
stances, except where equivalence in effect has been
proven between intervention and control group [50].
Costs are likely to fall on patients, their families and the
state. The health care resources consumed will reflect the
costs of organising and operating peer support in addition
to standardised primary diabetes care. These costs will
reflect the time input of health professionals and fixed or
overhead costs, including any new equipment and capital
expenditure. All contacts of patients with the health serv-
ices will be recorded and valued, including general prac-
tice use, hospital attendances (both outpatient clinic and
diabetes centre visits), admissions and drug prescriptions.
Travel and time costs will also be calculated. The cost of
the peer support system will be a major component of
overall intervention costs. Estimates will be made of the
work and leisure time foregone by peer support workers
and monetary valuations will be estimated as part of the
opportunity cost methodology. Training costs will also be
measured and valued. Patient and family costs will
include any out-of-pocket expenses and any own time
input into the treatment process, evaluated using an
opportunity cost methodology.
Discussion
Diabetes self management training has traditionally been
delivered in a didactic manner with emphasis on impart-
ing knowledge. However this approach has been shown to
be ineffective in changing the behaviour of individuals
with type 2 diabetes and improving metabolic control
[51]. An alternative approach such as peer support may
improve these outcomes. This approach is based on a
social support theoretical framework rather than an edu-
cational or psychological framework and the outcomes we
have selected for the study reflect this underlying theoret-
ical framework. The potential advantage of peer support is
that it focuses on the impact of the illness on daily life
rather than on medical information about illness. The
group meeting components of the intervention in this
study are designed to build on the lay element of peer sup-
port through the encouragement of the sharing of experi-
ences and exchanges between participants. Peer support is
a complex intervention and a strength of this study has
been the use of the MRC Framework for the evaluation of
randomized controlled trial of complex interventions
designed to improve health outcomes [24]. Details of the
initial phases of the framework leading to the finalisation
of this protocol are presented elsewhere. (BMC Health
Services Research, in press). The study is specifically based
in the general practice setting and empowers and supports
practice staff in the recruitment of participants and peer
supporters and data collection. This approach embeds the
study in the real world of primary care and will increase
the generalisability of results. An additional strength of
the study is its duration of two years, which allows us to
test the sustainability of a peer support intervention in a
clinical setting over time.
Peer supporters are central to the study and methods of
supporting them in their role have been identified. The
project manager is a source of advice and support for peer
supporters. They are also encouraged to turn to their GP
and practice nurse who are the clinicians responsible for
the care of all patients within each peer support group.BMC Family Practice 2007, 8:45 http://www.biomedcentral.com/1471-2296/8/45
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In summary, peer support is a complex intervention and
evaluating such an intervention presents challenges to
researchers. This study aims to determine whether a peer
support programme for patients with type 2 diabetes
improves biophysical and psychosocial outcomes and
whether it is an acceptable, cost effective intervention in
the primary care setting.
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